Related Experiment Video
Updated: Jun 7, 2025
Behavioral Disturbances: An Innovative Approach to Monitor the Modulatory Effects of a Nutraceutical Diet
Published on: January 3, 2017
Effect of a Whole-Food Plant-Based Diet on Postprandial Sleepiness: A Pilot Study
Anastasiia Polianovskaia1, Jay T Sutliffe2, Nanette V Lopez2
1Division of Allergy, Pulmonary and Sleep Medicine, Mayo Clinic, Jacksonville, FL, USA (AP, JC).
Background:
Postprandial sleepiness refers to the state of excessive drowsiness that occurs after consuming a meal. This transient phenomenon is experienced by many individuals, often leading to decreased productivity and impaired cognitive performance. This study examined the effect of a whole-food plant-based (WFPB) diet on postprandial sleepiness.
Methods:
Ten participants who had postprandial sleepiness who were on a typical American diet transitioned to a WFPB dietary pattern for 21 days. Postprandial sleepiness was assessed using the Epworth Sleepiness Scale (ESS) questionnaire, focusing on Q7 "sitting quietly after lunch without alcohol" as well as Q5 "lying down to rest in the afternoon when circumstances permit."
Results:
The participants had a mean age of 44 +/- 15 years, with 30% being male. There was a statistically significant reduction in sleepiness measured by ESS Q7 (median change = -1, P = .012) and ESS Q5 (median change = -1.5, P = .008). Moreover, there was a statistically significant decrease in overall ESS scores (median change = -8.0, P = .006), and weight (median change = -2.9 kg, P = .006).
Conclusion:
Participants demonstrated significant improvement in postprandial sleepiness-related situations. Our findings showed that the WFPB diet may have potential benefits for reducing postprandial and overall daytime sleepiness.
Related Concept Videos
01:13Insufficient Sleep and Sleep Deprivation
Sleep deprivation is a more severe form of sleep loss...
01:54The Placebo Effect
02:20Correlations
01:17Sedatives and Hypnotics Drugs: Miscellaneous Agents
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
01:11Understanding Sleep
The circadian rhythm, a nearly 24-hour cycle, is deeply influenced by environmental light cues. Light exposure directly affects the hypothalamus, which in turn regulates...
02:07Blind Procedures